A comparative trial of zidovudine administered every four versus every twelve hours for the treatment of advanced HIV disease.
Shepp DH, Ramirez-Ronda C, Dall L, Pollard RB, Murphy RL, Kessler H, Sherer R, Mertz G, Perez G, Gocke DJ, Greenberg SB, Petersen E, Frank I, Moore MD, McKinnis R, Rooney JF.
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 1;15(4):283-8.PMID: 9292587 [PubMed - indexed for MEDLINE]Related articles